<SEC-DOCUMENT>0001193125-18-189435-index.html : 20180611 <SEC-HEADER>0001193125-18-189435.hdr.sgml : 20180611 <ACCEPTANCE-DATETIME>20180611161718 ACCESSION NUMBER: 0001193125-18-189435 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 6 FILED AS OF DATE: 20180611 DATE AS OF CHANGE: 20180611 EFFECTIVENESS DATE: 20180611 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SANGAMO THERAPEUTICS, INC CENTRAL INDEX KEY: 0001001233 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 680359556 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-225552 FILM NUMBER: 18892178 BUSINESS ADDRESS: STREET 1: 501 CANAL BLVD STREET 2: POINT RICHMOND TECH CNTR. CITY: RICHMOND STATE: CA ZIP: 94804 BUSINESS PHONE: 5109706000 MAIL ADDRESS: STREET 1: 501 CANAL BLVD STREET 2: POINT RICHMOND TECH CNTR. CITY: RICHMOND STATE: CA ZIP: 94804 FORMER COMPANY: FORMER CONFORMED NAME: SANGAMO BIOSCIENCES INC DATE OF NAME CHANGE: 20000208 </SEC-HEADER> <DOCUMENT> <TYPE>S-8 <SEQUENCE>1 <FILENAME>d603403ds8.htm <DESCRIPTION>S-8 <TEXT> Document 1 - file: d603403ds8.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>d603403dex51.htm <DESCRIPTION>EX-5.1 <TEXT> Document 2 - file: d603403dex51.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>d603403dex231.htm <DESCRIPTION>EX-23.1 <TEXT> Document 3 - file: d603403dex231.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>4 <FILENAME>d603403dex991.htm <DESCRIPTION>EX-99.1 <TEXT> Document 4 - file: d603403dex991.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>5 <FILENAME>d603403dex992.htm <DESCRIPTION>EX-99.2 <TEXT> Document 5 - file: d603403dex992.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>g603403g0607084625516.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: g603403g0607084625516.jpg
</DOCUMENT> </SEC-DOCUMENT>